|
ARDX
|
Ardelyx, Inc.
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BAX
|
Baxter International Inc.
|
US
|
NYSE
|
|
CALT
|
Calliditas Therapeutics AB
|
US
|
NASDAQ
|
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
|
DVA
|
DaVita HealthCare Partners Inc.
|
US
|
NYSE
|
|
FMS
|
Fresenius Medical Care AG
|
US
|
NYSE
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
|
PIRS
|
Pieris Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
RMTI
|
Rockwell Medical, Inc.
|
US
|
NASDAQ
|
|
GNHAY
|
Vifor Pharma Ag ADR
|
US
|
OTC
|
|
RVXCF
|
Resverlogix Corp
|
US
|
OTC
|
|
ODX
|
Omega Diagnostics Group Plc
|
UK
|
LSE
|
|
531349
|
Panacea Biotec Limited
|
IN
|
BSE
|
|
2M6
|
Medtronic PLC
|
DE
|
F
|
|
337
|
Corbus Pharmaceuticals Holding
|
DE
|
F
|
|
002022
|
Shanghai Kehua Bio-Engineering Co Ltd
|
CN
|
SHE
|
|
600829
|
HPGC Renmintongtai Pharmaceutical Corp
|
CN
|
SHG
|